|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, July 14, 2011 ) Boca Raton, FL -- The world accounts for 16 billion injections each year, with the U.S. alone spending nearly $2 billion annually in treatment costs for needle-stick injuries, proving to be both a costly and serious health concern. In addition, the fear of needles is often underestimated and is a phobia that affects at least 10 percent of our world population. Now, imagine a system that eliminates the use of needles altogether. PharmaJetÂ’s needle-free product delivers vaccines and medications by means of a narrow, high velocity fluid jet, which penetrates the skin in less than 1/3 of a second.
FDA-cleared for marketing, their original needle-free device delivers a 0.5ml volume of liquid either intramuscularly (IM) where many vaccines are routinely delivered, or into the subcutaneous (SC) layer, between the skin and muscle.
In March 2011, PharmaJet received the first FDA clearance for a needle-free device that delivers 0.1mL volume intradermally (ID), or into the top layers of skin, where the immune system is very active, meaning a very effective vaccination, using only 1/5 the amount of vaccine. This potential dose-sparing will maximize cost savings, while providing for expanded coverage of vaccines that could be in short supply.
PharmaJetÂ’s Needle-free, single-use syringe benefits the healthcare worker by eliminating the risk of needle stick injuries while protecting the patient from cross-contamination and needle-reuse. The systems are also environmentally friendly, as there is no needle sharps disposal, and the components can be recycled.
JL Haber, Vice President of Programming at Multi Media Productions, added, “With a unique approach to the needs of the medical industry, PharmaJet was a natural fit for our show. We are excited to have them as a guest on our program.”
About PharmaJet
PharmaJetÂ’s needle-free injection technology delivers drugs and vaccines to intramuscular, subcutaneous and intradermal tissue depths. PharmaJet injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating needle-stick risk and the burden of sharps waste management. Further benefits of PharmaJet injectors include the potential for dose-sparing of vaccines, reducing the overall cost of vaccine delivery.
The PharmaJet system has been well received in the developed world, and is also extremely advantageous in the developing world due to its usability, affordability and inherent safety features. For more information on PharmaJetÂ’s needle-free injection technology, please contact us, or visit http://www.pharmajet.com
About 21st Century Health
21st Century Health is an award winning targeted business show that is independently produced by Multi-Media Productions. The show provides its business viewers an in depth opportunity to find solutions to the industry problems from some of the top business leaders from across the world. Each exclusive segment is taped in our state of the art South Florida Studio.
Once selected, companies are able to present their story and solutions to industry problems in an exclusive way that sets their company apart from the others. With more than 6,000 companies participating on over 600 shows, 21st Century Health continues to be the premier and targeted outlet for the latest business stories.
21st Century Health airs on various national cable networks that are viewed by over 100 million viewers nationwide as well as internationally via DirecTV and Dish Network. The show can also be viewed through video on demand via http://www.21chtv.com. The 21CHTV Series is also available at more than 27 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.21chtv.com.
Multi-Media Productions USA
Megan Vieira
561-988-9449 ext.355
mvieira@mmpusa.com 
Source: EmailWire.com
|
|
|
|
